
	September 27, 2025
Unaudited Condensed Consolidated Balance Sheets:	As Previously Reported		Adjustments (B)			As Restated
Assets
Current Assets
Cash and cash equivalents	$	50,918	$	—		$	50,918
Accounts receivable, net of allowance for credit losses of $2,039 at September 27, 2025	111,269		—			111,269
Contract assets	248,402		(1,335)			247,067
Inventories	192,817		1,902			194,719
Production cost of contracts	5,685		—			5,685

Other current assets	72,259		5			72,264

Total Current Assets	681,350		572			681,922
Property and Equipment, Net of Accumulated Depreciation of $202,781 at September 27, 2025	107,361		—			107,361
Operating Lease Right-of-Use Assets	42,173		—			42,173
Goodwill	244,600		—			244,600
Intangibles, Net	137,027		—			137,027
Deferred Income Taxes	18,172		1,151		(A)	19,323
Other Assets	17,887		—			17,887
Total Assets	$	1,248,570	$	1,723		$	1,250,293
Liabilities and Shareholders’ Equity
Current Liabilities
Accounts payable	$	85,281	$	—		$	85,281
Contract liabilities	34,450		—			34,450
Accrued and other liabilities	194,227		90		(A)	194,317
Operating lease liabilities	7,796		—			7,796
Current portion of long-term debt	12,500		—			12,500

Total Current Liabilities	334,254		90			334,344
Long-Term Debt, Less Current Portion	215,046		—			215,046
Non-Current Operating Lease Liabilities	36,129		—			36,129

Other Long-Term Liabilities	14,096		1,462		(A)	15,558
Total Liabilities	599,525		1,552			601,077
Commitments and Contingencies
Shareholders’ Equity
Common Stock - $0.01 par value; 35,000,000 shares authorized; 14,945,835 shares issued and outstanding at September 27, 2025	149		—			149

Additional Paid-In Capital	229,980		15,278		(A)	245,258
Retained Earnings	412,093		(15,107)			396,986
Accumulated Other Comprehensive Income	6,823		—			6,823
Total Shareholders’ Equity	649,045		171			649,216
Total Liabilities and Shareholders’ Equity	$	1,248,570	$	1,723		$	1,250,293


	Three Months Ended September 27, 2025							Nine Months Ended September 27, 2025
Unaudited Condensed Consolidated Statements of Operations:	As Previously Reported		Adjustments (B)			As Restated		As Previously Reported		Adjustments (B)			As Restated
Net Revenues	$	212,558	$	1,864		$	214,422	$	608,932	$	(1,226)		$	607,706
Cost of Sales	156,083		(611)			155,472		447,122		(1,793)			445,329
Gross Profit	56,475		2,475			58,950		161,810		567			162,377
Selling, General and Administrative Expenses	36,267		(2,258)		(A)	34,009		106,820		6,882		(A)	113,702
Restructuring Charges	583		—			583		1,617		—			1,617
Litigation Settlement and Related Costs, Net	99,675		—			99,675		99,675		—			99,675
Operating Loss	(80,050)		4,733			(75,317)		(46,302)		(6,315)			(52,617)
Interest Expense	(2,927)		—			(2,927)		(9,198)		—			(9,198)


Other Income, Net	—		—			—		1,746		—			1,746
Loss Before Taxes	(82,977)		4,733			(78,244)		(53,754)		(6,315)			(60,069)
Income Tax Benefit	(18,531)		1,114		(A)	(17,417)		(12,372)		(1,026)		(A)	(13,398)
Net Loss	$	(64,446)	$	3,619		$	(60,827)	$	(41,382)	$	(5,289)		$	(46,671)
Loss Per Share
Basic loss per share	$	(4.30)				$	(4.06)	$	(2.77)				$	(3.13)
Diluted loss per share	$	(4.30)				$	(4.06)	$	(2.77)				$	(3.13)
Weighted-Average Number of Common Shares Outstanding
Basic	14,978					14,978		14,925					14,925
Diluted	14,978					14,978		14,925					14,925


	Three Months Ended September 27, 2025						Nine Months Ended September 27, 2025
Unaudited Condensed Consolidated Statements of Comprehensive Loss:	As Previously Reported		Adjustments		As Restated		As Previously Reported		Adjustments		As Restated
Net Loss	$	(64,446)	$	3,619	$	(60,827)	$	(41,382)	$	(5,289)	$	(46,671)
Other Comprehensive Loss, Net of Tax:
Amortization of actuarial losses and prior service costs, net of tax of $6 and $19 for the three and nine months ended September 27, 2025, respectively.	19		—		19		58		—		58

Change in net unrealized losses on cash flow hedges, net of tax benefit of $203 and $1,388 for the three and nine months ended September 27, 2025.	(687)		—		(687)		(4,619)		—		(4,619)
Other Comprehensive Loss, Net of Tax	(668)		—		(668)		(4,561)		—		(4,561)
Comprehensive Loss	$	(65,114)	$	3,619	$	(61,495)	$	(45,943)	$	(5,289)	$	(51,232)


	Nine Months Ended September 27, 2025
Unaudited Condensed Consolidated Statement of Cash Flows:	As Previously Reported		Adjustments (B)			As Restated
Cash Flows from Operating Activities
Net Loss	$	(41,382)	$	(5,289)	(A)	$	(46,671)
Adjustments to Reconcile Net Loss to
Net Cash Provided by Operating Activities:
Depreciation and amortization	25,195		—			25,195
Non-cash operating lease cost	6,631		—			6,631



Stock-based compensation expense	17,511		7,344		(A)	24,855
Deferred income taxes	(14,563)		(984)			(15,547)

Provision for credit losses	10		—			10


Gain on sale of property and other assets	(1,746)		—			(1,746)
Litigation settlement and related costs, net	97,667		—			97,667
Other	909		—			909
Changes in Assets and Liabilities:
Accounts receivable	(1,563)		—			(1,563)
Contract assets	(47,818)		1,226			(46,592)
Inventories	4,064		(1,793)			2,271
Production cost of contracts	790		—			790
Other assets	(67)		—			(67)
Accounts payable	10,011		—			10,011
Contract liabilities	5		—			5
Operating lease liabilities	(5,888)		—			(5,888)
Accrued and other liabilities	(8,484)		(504)		(A)	(8,988)
Net Cash Provided by Operating Activities	41,282		—			41,282
Cash Flows from Investing Activities
Purchases of property and equipment	(11,172)		—			(11,172)
Proceeds from sale of property and other assets	1,979		—			1,979
Proceeds from sale of assets	138		—			138



Net Cash Used in Investing Activities	(9,055)		—			(9,055)
Cash Flows from Financing Activities


Borrowings from senior secured revolving credit facility	25,000		—			25,000
Repayments of senior secured revolving credit facility	(33,800)		—			(33,800)

Repayments of term loan	(6,250)		—			(6,250)
Repayments of other debt	(279)		—			(279)






Net cash paid upon issuance of common stock under stock plans	(3,119)		—			(3,119)
Net Cash Used in Financing Activities	(18,448)		—			(18,448)
Net Increase in Cash and Cash Equivalents	13,779		—			13,779
Cash and Cash Equivalents at Beginning of Period	37,139		—			37,139
Cash and Cash Equivalents at End of Period	$	50,918	$	—		$	50,918